| Literature DB >> 33767437 |
Zeina Nehme1,2, Sébastien Pasquereau1, Sandy Haidar Ahmad1,2, Alain Coaquette3, Chloé Molimard4, Franck Monnien4, Marie-Paule Algros4, Olivier Adotevi5, Mona Diab Assaf2, Jean-Paul Feugeas5, Georges Herbein6,7.
Abstract
A growing body of evidence is recognizing human cytomegalovirus (HCMV) as a potential oncogenic virus. We hereby provide the first experimental in vitro evidence for HCMV as a reprogramming vector, through the induction of dedifferentiation of mature human mammary epithelial cells (HMECs), generation of a polyploid giant cancer cell (PGCC) phenotype characterized by sustained growth of blastomere-like cells, in concordance with the acquisition of embryonic stem cells characteristics and epithelial-mesenchymal plasticity. HCMV presence parallels the succession of the observed cellular and molecular events potentially ensuing the transformation process. Correlation between PGCCs detection and HCMV presence in breast cancer tissue further validates our hypothesis in vivo. Our study indicates that some clinical HCMV strains conserve the potential to transform HMECs and fit with a "blastomere-like" model of oncogenesis, which may be relevant in the pathophysiology of breast cancer and other adenocarcinoma, especially of poor prognosis.Entities:
Mesh:
Year: 2021 PMID: 33767437 DOI: 10.1038/s41388-021-01715-7
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867